Category Archives: MS Treatment

The Ontario Human Rights Tribunal has dismissed an application by an Eastern Ontario woman who claimed the Ontario government discriminated against her by refusing to pay for a controversial treatment she received for multiple sclerosis in Egypt. Judy Butcher, a 49-year-old resident of Jasper, near Merrickville, paid $7,000 for balloon angioplasty at an Egyptian clinic two years ago to open blocked neck veins after the Ontario Health Insurance Plan refused to pay for the treatment. Sometimes called liberation treatment, the procedure was pioneered by Italian vascular surgeon Paolo Zamboni. It is considered experimental in Canada and is not performed here. But thousands of Canadians have travelled to other countries to obtain it since Zamboni published his findings in 2009. Butcher was diagnosed with MS in 1996. Before undergoing the Zamboni procedure, the disease had progressed to the point that she was confined to a wheelchair and often in excruciating pain. But after undergoing the so-called CCSVI (chronic cerebrospina venous insufficiency) treatment, her pain subsided, her circulation improved and she could walk with the aid of a cane. She was even able to regain her drivers licence. Butcher filed her complaint with the human rights tribunal in February 2011, alleging she … Continue reading →

Winnipeg Free Press - PRINT EDITION By: Staff Writer Posted: 1:00 AM | Comments: 'LIBERATION THERAPY' is the name given to a controversial process of treating multiple sclerosis (MS). In 2009, Italian vascular surgeon Paulo Zamboni claimed to have found a connection between MS and constricted veins in the neck. His procedure involved putting small balloons through the veins, like angioplasty used to clear blocked arteries. Initially, the Internet was full of stories of miraculous recoveries after this procedure. However, more people are saying the procedure did not work for them, or that any improvements from liberation therapy didn't last. The federal government is funding a national clinical study of liberation therapy. Up to 25 Manitobans with MS will undergo the liberation treatment, along with samples of people in other provinces. It will be a double-blind study, with some people getting the treatment, and some getting sham treatment. However, people who receive the placebo will have the opportunity to receive liberation therapy after the study. The study in Manitoba is being managed by the Manitoba Health Research Council. The four types of MS Relapsing remitting MS: Typified by attacks that last a few hours to a few months, but there … Continue reading →

Jackson, MS (PRWEB) August 08, 2013 Dr. Roger B. Parkes offers the Laser Assisted New Attachment Procedure (LANAP), which is the only FDA cleared laser gum disease treatment. Jackson patients who will receive dental implants may want to inquire about using LANAP to prepare their mouths for treatment. Gum disease is considered the primary cause of tooth loss in American adults; so many times gum disease and dental implants go hand in hand. Dr. Parkes recommends that any patient who is suffering from the symptoms of gum disease, such as redness, sensitivity, bleeding or inflammation of the gum, or tooth loss, seek treatment prior to receiving dental implants. Tooth loss as a result of gum disease can be prevented in many cases by timely gum disease treatment. Jackson patients may now receive gentler, less invasive gum surgery. Dr. Parkes offers LANAP to eligible patients. LANAP uses a high-tech laser to remove damaged tissue. The laser is so precise that it leaves healthy tissue unharmed. LANAP also stimulates bone to regenerate, leading to healthier bone density. This can prevent tooth loss for patients who were at risk of losing them. In cases where teeth have already been lost or cannot be … Continue reading →

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced the pricing of an underwritten public offering of 12 million shares of its common stock at a price to the public of $1.50 per share. The gross proceeds to Opexa from this offering are expected to be approximately $18 million, before deducting underwriting discounts and commissions and other estimated offering expenses. All of the shares in the offering are to be sold by Opexa. Opexa has also granted the underwriters a 30-day option to purchase up to an additional 1.8 million shares of common stock to cover over-allotments, if any. The offering is expected to close on or about August 13, 2013, subject to customary closing conditions. Opexa intends to use the net proceeds from the offering to fund further clinical development of Tcelna in an ongoing Phase IIb clinical study of patients with Secondary Progressive MS as well as the expenses of its operations during such development and for general corporate purposes. Opexa may also use a portion of the net proceeds to repay all or a portion of its outstanding convertible secured promissory … Continue reading →

Former Victorian Premier Joan Kirner has begun treatment for cancer. Ms Kirner, the state's first female premier, was diagnosed last month and has started chemotherapy and radiation treatment for oesophageal cancer. 'I am very grateful for the medical care and attention from my doctors, and the staff and management team at Peter Mac,' she said in a statement. 'I would also like to thank my friends and family for their terrific support.' Ms Kirner and her family asked for privacy during her treatment and recovery. Ms Kirner was elected Labor leader and became premier when John Cain resigned in 1990. Victorian Opposition leader Daniel Andrews offered his support and best wishes to the state's first and only female premier. Ms Kirner is a tireless advocate for Labor values and has continued to work for the movement in a range of roles since retiring from the party, he said in a statement. 'Our thoughts are with Joan and her family at this time,' he said. See the article here: Former Vic premier treated for cancer … Continue reading →

Former Victorian Premier Joan Kirner has started treatment for oesophageal cancer. Source: AAP VICTORIA'S first and only female premier Joan Kirner will use her strength and tenacity to fight her latest challenge - cancer, her supporters say. Ms Kirner, 75, was diagnosed last month with oesophageal cancer and has begun chemotherapy and radiation treatment at Melbourne's Peter MacCallum Cancer Centre. She thanked her doctors, family and friends for their support. "I am very grateful for the medical care and attention from my doctors, and the staff and management team at Peter Mac," she said in a statement. "I would also like to thank my friends and family for their terrific support." Ms Kirner was elected Labor leader and became premier when John Cain resigned in 1990. She was premier until 1992, when the coalition won the election in a landslide result. Victorian Premier Denis Napthine describes Ms Kirner as a great Victorian. "She's been a real leader for Victorian politics, the Victorian community and particularly Victorian women," the coalition leader told reporters. "Our thoughts are with her and we wish her all the best in this tough fight." See original here: Ex-Vic premier Joan Kirner has cancer … Continue reading →

Joan Kirner's ailing health in recent years has not stopped her from working as a community activist and advocate for the advancement of women and social justice. Source: News Limited FORMER Premier Joan Kirner is undergoing treatment for cancer. In a statement Ms Kirner said she was diagnosed last month and had started chemotherapy and radiation treatment. "I am very grateful for the medical care and attention from my doctors, and the staff and management team at Peter Mac," she said. "I would also like to thank my friends and family for their terrific support." Ms Kirner and her family asked for privacy during her treatment and recovery. Premier Denis Napthine said Ms Kirner's battle was "sad news" and Victorians' thoughts and prayers were with the former Premier. "This is sad news and all our thoughts and prayers are with Joan as she battles oesophageal cancer, our thoughts are with her and with her family," Dr Napthine said. "Joan Kirner has been a great Victorian, she has been a real leader for Victorian politics, the Victorian community and particularly Victorian women and our thoughts are with her and we wish her all the best in this tough fight." Opposition Leader … Continue reading →

Former Victorian premier Joan Kirner is undergoing treatment for oesophageal cancer. Ms Kirner was diagnosed last month and has started chemotherapy and radiation treatment. "I am very grateful for the medical care and attention from my doctors and the staff and management team at Peter Mac," she said in a statement. Ms Kirner was premier of Victoria between 1990 and 1992. Opposition leader Daniel Andrews says Ms Kirner is a tireless advocate for Labor values and has continued to work for the party since her retirement. "Our thoughts are with Joan and her family at this time as she undertakes treatment," Mr Andrews said. Premier Denis Napthine wished her well with her treatment. "Joan Kirner has been a great Victorian. She's been a real leader for Victorian politics, the Victorian community and particularly Victorian women," he said. "Our thoughts are with her and we wish her all the best in this tough fight." Ms Kirner is the co-founder of Emily's List, an organisation dedicated to promoting the role of women in politics and rights in Australia. Read more here: Former Victorian premier Joan Kirner treated for oesophageal cancer … Continue reading →

LONDON, Aug. 5,2013 /PRNewswire/ --GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results confirm the reassuring safety profile of Sativex and provide further evidence of long-term efficacy. The study was a 12 month multicentre, double-blind, randomised parallel group, placebo-controlled study in 121 patients with MS spasticity. The study was required as a post-approval commitment by the UK regulatory authority, the Medicines and Healthcare products Regulatory agency (MHRA), with the primary objective of evaluating whether Sativex may have long term adverse effects on cognitive function or mood. The primary endpoint was the change in cognitive function as assessed by the total Paced Auditory Serial Addition Test (PASAT) score from baseline to end of treatment. Mood was assessed by the Beck Depression Inventory-II. There was a slight improvement in the PASAT score from the beginning to the end of the study in both the Sativex and placebo groups, thus confirming that there is no evidence of long-term cognitive … Continue reading →

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending … Continue reading →